Healthcare IT Today January 25, 2022
After many years of working fruitlessly to establish it as the leading healthcare AI platform, IBM has agreed to sell Watson Health. The deal, which was reportedly in the $1 billion range, turns over a bundle of assets including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and some imaging software products to tech-focused investment firm Francisco Partners.
This brings the Watson Health assets into an investment house with a history of having invested in more than 400 technology companies. Francisco Partners’ current and past investments in the sector include Availity, eSolutions, Capsule, GoodRx and Zocdoc.
The sale comes as a somewhat inauspicious end to the inauspicious tale of Watson Health, which was launched in 2015 to significant fanfare...
Today's Sponsors
Today's Sponsor